文献速递生殖医学妇科

生育力受损作为健康与生存的标志:丹麦双胞胎队列研究

Impaired fecundity as a marker of health and survival: a Danish twin cohort study.
PubMed 文献 · Hum Reprod · 2021-01-01

该前瞻性队列研究纳入7825名女性和6279名男性丹麦双胞胎,分析自报首次妊娠时间(TTP)与死亡和住院的关联。结果发现TTP≥18个月与女性死亡率升高(HR=1.46;95%CI 1.15,1.87)及男女住院率升高相关,女性存在剂量反应关系。

要点

  • 女性TTP≥18个月与死亡率升高相关(HR=1.46;95%CI 1.15,1.87)。
  • 男女TTP≥18个月均与住院率升高相关。
  • 女性死亡和住院风险随TTP延长呈剂量反应关系。

核心结论

  • 长TTP是女性死亡率升高和男女住院率升高的标志。
  • 生育力似乎与整体健康正相关,可能是未来健康和生存的通用标志。

研究设计与样本

  • 前瞻性队列研究,纳入7825名女性和6279名男性丹麦双胞胎,年龄≥18岁,来自1994年和1998年全国双胞胎调查,随访至2018年。
  • TTP为自报首次妊娠时间,分类截断点为2、10和18个月。

主要发现

  • 女性TTP≥18个月相比<2个月,死亡率HR=1.46(95%CI 1.15,1.87)。
  • 男性TTP 10-17个月死亡率HR=1.31(95%CI 0.98,1.74)。
  • 女性TTP≥18个月住院率HR=1.21(95%CI 1.0-1.41),男性HR=1.16(95%CI 1.00-1.35)。
  • 男性TTP 2-9个月住院率HR=1.14(95%CI 1.01-1.30)。
  • 女性死亡(P=0.022)和住院(P=0.018)均存在剂量反应关系。

临床怎么用

  • 可将长TTP作为女性健康风险评估的提示因素。
  • 对TTP延长的个体关注共病和住院风险。

局限性

  • 未考虑伴侣生育力。
  • 无法获取部分潜在混杂因素信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is fecundity, measured as self-reported time to first pregnancy (TTP), a marker for subsequent health and survival? SUMMARY ANSWER: Long TTP was a marker for increased mortality among women and higher hospitalization rates for both women and men. WHAT IS KNOWN ALREADY: Poor semen quality has been linked to increased mortality and morbidity from a wide range of diseases. Associations among fecundity, health and survival among women are still uncertain and studies on actual measures of fecundity and health outcomes are rare. STUDY DESIGN, SIZE, DURATION: We performed a prospective cohort study of 7825 women and 6279 men, aged 18 and above with measures on first TTP, who participated in one of the Danish nation-wide twin surveys in 1994 (twins born 1953-1976) and 1998 (twins born 1931-1952). They were followed-up for mortality and hospital admissions from the interview until 2018. PARTICIPANTS/MATERIALS, SETTING, METHODS: Twins were identified in the Danish Twin Registry and linked to Danish registers. TTP was restricted to the first pregnancy as a categorical outcome with cut-off points at 2, 10 and 18 months. We analysed the association between TTP and survival using a Cox proportional hazards model estimating hazards ratios (HRs) with 95% confidence intervals (CIs). Fine-Gray survival models were used to estimate sub-hazard ratios for specific causes of death allowing for competing risks. Using negative binomial regression, we estimated incidence rate ratios (IRRs) with 95% CIs for all-cause and cause-specific hospitalizations. All analyses were stratified by sex and adjusted for age at interview, birth cohorts, age at first attempt to become pregnant, smoking, years in school and BMI. MAIN RESULTS AND THE ROLE OF CHANCE: In the total study population, 49.9% of women and 52.7% of men reported a TTP of less than 2 months, 30.8% of women and 29.6% of men reported a TTP of 2-9 months, 6.6% of women and 5.7% of men reported a TTP of 10-17 months, and 13.3% of women and 12.0% of men reported a TTP of 18 months or more. Among 1305 deaths, we found a higher mortality for women (HR = 1.46; 95% CI 1.15, 1.87) with a TTP of ≥18 months relative to those with a TTP of <2 months, while the highest mortality was indicated for men with a TTP of 10-17 months (HR = 1.31; 95% CI 0.98, 1.74). Among 53 799 hospitalizations, we found an increased hospitalization rate among women (HR = 1.21; 95% CI 1.0-1.41) and men (HR = 1.16; 95% CI 1.00-1.35) with a TTP of ≥18 months, and for men with a TTP of 2-9 months (HR = 1.14; 95% CI 1.01-1.30). A dose-response relationship was found for women regarding both mortality (P = 0.022) and hospitalizations (P = 0.018). Impaired fecundity was associated with a wide range of diseases and some causes of death, indicating a multi-factorial causal influence on fecundity, especially among women. LIMITATIONS, REASONS FOR CAUTION: A major limitation was that fecundity depends on both partners, which was not considered in this study. Moreover, we could not obtain information on a number of potential confounders. WIDER IMPLICATIONS OF THE FINDINGS: Fecundity seems positively correlated with overall health and may be a universal marker of future health and survival. These results add knowledge to the limited findings showing that reduced fecundity in women and poor semen quality in men may reflect worse health and a shorter life, particularly among women. STUDY FUNDING/COMPETING INTEREST(S): This study was funded by NIH grant HD096468 (M.L.E., T.K.J. and R.L.J.). The authors declare that they have no competing interests. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Ahrenfeldt LJ, Möller S, Wensink MJ, et al. Impaired fecundity as a marker of health and survival: a Danish twin cohort study. Hum Reprod. 2021. PMID: 34009293. doi:10.1093/humrep/deab077

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。